Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections

In this cross-sectional study the investigators will examine two populations: young adults with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on > 2 insulin injections per day. The sample size for this observational study will be up to 125 patients. The investigators will issue a Common Sensing GoCap bluetooth-enabled pen cap that fits on the end of Solostar Lantus and Apidra insulin pens; this pen cap registers the position of the insulin pen plunger and automatically sends confirmation of dose delivery to a smartphone app.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Behavior Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Health Behavior Hyperinsulinism Insulin Insulin Resistance Medication Adherence Metabolic Diseases Nutritional and Metabolic Diseases Patient Acceptance of Health Care Patient Compliance Technology Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Joslin DIabetes Center

Boston, Massachusetts, 02215, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Type 1 diabetes or insulin-requiring Type 2 diabetes
> 2 insulin injections
Age 18-35 or older than 65 years
Use of glargine insulin as basal insulin
Stable insulin doses for past 3 months

Exclusion criteria

Previous tape/adhesive allergies with CGM sensors
Visual or cognitive impairment with inability to self-administer insulin

Treatment and study plan

Primary outcomes

Number of Missed Insulin Doses

Time frame: 4 week use of blue tooth pen cap

Sponsors and collaborators

Lead sponsor

Joslin Diabetes Center

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2018
First posted: Sep 26, 2016
Registry last updated: Aug 14, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed